89bio Inc logo

ETNB

89bio Inc

$15.94

Earnings Summary

Net Profits
$-38.39Mn

Highlights

Net Profits:

89bio Inc’s net profit fell -53.24% since last year same period to $-38.39Mn in the Q2 2023. On a quarterly growth basis, 89bio Inc has generated -33.14% fall in its net profits since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the 89bio Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.66
EPS Estimate Current Year
-0.66

Highlights

EPS Estimate Current Quarter:

89bio Inc’s earning per share (EPS) estimates for the current quarter stand at -0.66 - a 17.5% jump from last quarter’s estimates.

EPS Estimate Current Year:

89bio Inc’s earning per share (EPS) estimates for the current year stand at -0.66.

Key Ratios

Key ratios of the 89bio Inc post its Q1 2023 earnings

Return on Assets (ROA)
-0.24
Return on Equity (ROE)
-0.45

Highlights

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. 89bio Inc’s return on assets (ROA) stands at -0.24.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. 89bio Inc’s return on equity (ROE) stands at -0.45.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-08-11
-1.05
-1.23
-17.14%
2022-05-12
-1.29
-1.26
2.33%
2022-11-10
-0.8
-0.57
28.75%